BillionToOne Revolutionizes Prenatal Care with Dual Launch of Innovative NIPTs BillionToOne introduces two groundbreaking non-invasive prenatal tests, enhancing fetal antigen screening for a safer pregnancy experience. Learn more!

BillionToOne Revolutionizes Prenatal Care with Dual Launch of Innovative NIPTs #USA #Menlo_Park #Prenatal_Testing #BillionToOne #Fetal_Antigens

Minerva Clinic Recognized as a Top Prenatal Testing Service in APAC Region Minerva Clinic has been honored as the APAC 2025 Top New Prenatal Testing Service, highlighting its patient-centered approach to care.

Minerva Clinic Recognized as a Top Prenatal Testing Service in APAC Region #Japan #Tokyo #Prenatal_Testing #Minerva_Clinic #Genetic_Counseling

Understanding the Gap Between Cost and Trust in Prenatal Testing Facilities A recent survey reveals the concerns of pregnant women regarding the cost and reliability of prenatal testing facilities, spotlighting key factors influencing their choices.

Understanding the Gap Between Cost and Trust in Prenatal Testing Facilities #Japan #NIPT #Prenatal_Testing #Minato #Minerva_Clinic

BillionToOne Introduces Enhanced UNITY Fetal Risk Screen for Prenatal Testing BillionToOne has launched an upgraded version of the UNITY Fetal Risk™ Screen, enabling early assessment of numerous genetic conditions from a single blood sample.

BillionToOne Introduces Enhanced UNITY Fetal Risk Screen for Prenatal Testing #United_States #Menlo_Park,_California #Prenatal_Testing #BillionToOne #UNITY_Fetal_Risk

BillionToOne Achieves Major Milestone with One Million UNITY Prenatal Tests BillionToOne celebrates a significant achievement by surpassing one million UNITY prenatal tests, revolutionizing prenatal care with its non-invasive technology.

BillionToOne Achieves Major Milestone with One Million UNITY Prenatal Tests #USA #Menlo_Park #Unity #Prenatal_Testing #BillionToOne

BillionToOne Achieves Major Milestone with 100% Accuracy in Non-Invasive Fetal RhD Detection Study BillionToOne has announced groundbreaking results from a US study showcasing 100% accuracy in non-invasive fetal RhD detection, revolutionizing prenatal care.

BillionToOne Achieves Major Milestone with 100% Accuracy in Non-Invasive Fetal RhD Detection Study #United_States #Menlo_Park #Prenatal_Testing #BillionToOne #RhD_Detection

BillionToOne Achieves Impressive Revenue Growth Over 100% in 2024 BillionToOne, a leader in molecular diagnostics, reported over 100% revenue growth in 2024, driven by advancements in prenatal testing and oncology markets.

BillionToOne Achieves Impressive Revenue Growth Over 100% in 2024 #United_States #Menlo_Park #Prenatal_Testing #BillionToOne #Oncology_Liquid_Biopsy

Dr. Dennis Lo Honored with the 2025 March of Dimes Richard B. Johnston Prize March of Dimes announces Dr. Dennis Lo as the 2025 prize recipient for his groundbreaking work in non-invasive prenatal testing, enhancing maternal and infant health.

Dr. Dennis Lo Honored with the 2025 March of Dimes Richard B. Johnston Prize #USA #Arlington #March_of_Dimes #Dr._Dennis_Lo #Prenatal_Testing